Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA grants approval for first generic version of Viagra

March 10, 2016
Manufacturing and Production, Research and Development, Sales and Marketing FDA, Pfizer, Teva, erectile dysfunction, generic, viagra

The US Food and Drug Administration (FDA) has granted approval to the first generic version of Pfizer’s blockbuster erectile dysfunction …

News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

Two-drug combo shown to significantly shrink breast cancer in days

March 10, 2016
Medical Communications, Research and Development GSK, Herceptin, Novartis, Roche, Tyverb

Results of a clinical trial have revealed that Novartis’ Tyverb (lapatinib), in combination with Roche’s Herceptin (trastuzumab), can significantly shrink …

News
teva_copy

Teva issues US recall of amikacin sulfate injection due to glass identified in vials

March 10, 2016
Manufacturing and Production Teva, amikacin sulfate, glass, recall

Teva Pharmaceuticals has announced a voluntary recall of one lot of amikacin sulfate injection USP vials due to the potential …

News
msd_sanat_chattopadhyay_

New manufacturing boss for MSD

March 10, 2016
Manufacturing and Production, Medical Communications MSD, manufacturing

MSD has appointed Sanat Chattopadhyay president of the Merck Manufacturing Division (MMD) and an executive vice president of the company. …

Appointment
research_11

Researcher develops strategy to identify antimicrobial drugs that tackle drug-resistant pathogens

March 10, 2016
Manufacturing and Production, Research and Development anitmicrobial, drug discovery, drug repurposing, mohamed seleem, purdue university

A researcher from Purdue University’s College of Veterinary Medicine has developed a novel method of repurposing drugs to act as …

News
amarin_logo

Amarin wins case against FDA to promote Vascepa for off-label uses

March 10, 2016
Medical Communications, Research and Development, Sales and Marketing Amarin, FDA, first amendment, off label, vascepa

Amarin has announced a settlement with the US Food and Drug Administration (FDA) that resolves the dispute over the Irish-based …

News
lupin_pharma_logo

Lupin completes acquisition of US-based Gavis Pharmaceuticals

March 10, 2016
Research and Development, Sales and Marketing FDA, Gavis, Lupin, acquisition, generics

Indian drug manufacturer Lupin has announced the completion of its acquisition of New Jersey-based pharmaceutical firm, Gavis, in a deal …

News
patient_view

Survey reveals patient groups’ views on pharma industry

March 10, 2016
Research and Development, Sales and Marketing patientview

A new report, published by research and consultancy group PatientView, has revealed the attitude of more than 1,000 patient groups …

News
sharapova

Seven quick facts about meldonium – and why it will get Sharapova banned

March 10, 2016
Medical Communications, Research and Development 7 things, anti-doping, banned, maria sharapova, medlonum, reasons, susbtance

It’s made world headlines this week, but the drug meldonium would have been unknown to many before it emerged that …

Feature
angiochip

Engineers create lab-grown heart and liver tissue for drug testing and discovery

March 10, 2016
Manufacturing and Production, Research and Development 3D, angiochip, artificial heart, drug delivery, innovation, liver, vessels

Researchers at University of Toronto have developed “person-on-a-chip” technology which sees the growing of realistic human tissues outside the body. …

News
genmab

Genmab Darzalex success triggers second milestone payment

March 10, 2016
Research and Development, Sales and Marketing Genmab, Janssen, daratumumab, darzalex, follicular lymphoma

Genmab says it has reached a $5 million milestone in its daratumumab collaboration with Janssen as a result of success …

News
valeant

Valeant ends controversial litigation with R&O Pharmacy

March 10, 2016
Litigation, Philidor, Valeant, controversy, r&o pharmacy, scandal

Valeant has announced that, in conjunction with R&O Pharmacy, its has jointly requested that the Court dismiss the litigation between …

News
wkd_logo

Tackling Chronic Kidney Disease – early action will aid prevention this World Kidney Day 2016

March 10, 2016
Medical Communications, Research and Development

Today (10th March) marks World Kidney Day 2016. Now in its 11th year, it is the largest such event focused …

Feature
dr_amit_nathwani

Sanofi appoints Novartis executive Dr Ameet Nathwani executive VP and CMO

March 10, 2016
Medical Communications

Sanofi has announced the appointment of Dr Ameet Nathwani as a new member of its Executive Committee, and to the …

Appointment
anna_cmo

Rigel names Anne-Marie Duliege chief medical officer

March 9, 2016
Medical Communications

Biotech firm Rigel Pharmaceuticals (Nasdaq: RIGL) named Anne-Marie Duliege its chief medical officer, replacing Elliott Grossbard, who is retiring.Dr Grossbard will remain …

Appointment
shire_image_4

Shire launches long-acting ADHD drug in UK

March 9, 2016
Sales and Marketing ADHD, Shire

Shire has launched its long-acting ADHD drug Intuniv (guanfacine) in the UK, for children and adolescents aged 6-17. The treatment …

News
pfizer_building

Pfizer enters $5 billion share buyback deal with Goldman Sachs

March 9, 2016
Business Services, Research and Development Pfizer, Share buyback, Stock, markets

US drug major Pfizer (NYSE: PFE) on Wednesday said it has entered into an accelerated share repurchase agreement with Goldman, …

News
abpi_reception_close_7

Pharma industry’s contribution to NHS medicines bill tops £1 billion

March 9, 2016
Manufacturing and Production, Medical Communications, Research and Development ABPI, PPRS, goodwill, pharma industry

The pharmaceutical industry has now contributed over £1 billion to the Department of Health towards the cost of new medicines …

News

Late-stage Pfizer drug study shows significant reduction in haemophilia B bleeding

March 9, 2016
Research and Development BeneFIX, Pfizer, haemophilia B

Pfizer on Wednesday said late-stage trials for its drug candidate to treat haemophilia B showed prophylactic use resulted in significant reduction …

News

TiGenix says additional data for stem cell product affirms safety profile

March 9, 2016
Research and Development Crohn’s disease, TiGenix, crohn's disease, drug trial

Belgian biotech firm TiGenix said the results of a 52-week follow-up study of its trial drug for a stem-cell condition …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026